The Food and Drug Administration has approved a novel type of cholesterol-lowering drug developed by the pharmaceutical company Novartis. The treatment, called Leqvio, uses RNA to help keep levels of low-density lipoprotein (LDL) cholesterol in the blood low, which is important for people with certain cardiovascular…
Source: Gizmodo – FDA Approves a New RNA-Based Treatment to Lower Cholesterol